Recent Updates
Recently added Catalysts
PFE Positive Sentiment

Pfizer Invites Public to View and Listen to Webcast of November 3 Conference Call with Analysts

Tuesday, September 22, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Pfizer Inc. has announced a conference call scheduled for November 3, 2026, at 10:00 a.m. EST. The call aims to update investors on the company's third quarter performance. Participants can access the webcast and the performance report through Pfizer's investor website.

Market Sentiment Analysis

POSITIVE FACTORS

  • Pfizer is actively engaging with investors and the public.
  • The conference call will provide important updates on company performance.
  • Accessibility of the webcast promotes transparency.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+6%
120-day peak, hindsight
Typical move
1.3%
average across 15 past catalysts
Lead asset
ibuzatrelvir
Phase 1 · Healthy

Full Press Release Details

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10:00 a.m. EST on Tuesday, November 3, 2026. The purpose of the call is to provide an update on Pfizer’s results, as reflected in the company’s Third Quarter 2026 Performance Report, to be issued that morning. To view and listen to the webcast and view the Performance Report, visit our web site at www.pfizer.com/investors. I

Frequently Asked Questions

When is the Pfizer conference call scheduled?

The Pfizer conference call is scheduled for November 3, 2026, at 10:00 a.m. EST.

How can I access the Pfizer webcast?

You can access the Pfizer webcast on their investor website at www.pfizer.com/investors.

What will be discussed in the conference call?

The conference call will provide updates on Pfizer's third quarter 2026 performance.

Who can listen to the Pfizer conference call?

The conference call is open to both investors and the general public.

ShareAdd on Google
Tags: PFE Viatris Investor Conferences Healthcare Pfizer conference call investors Q3 2026
Last updated: Sep 22, 2026

Biotech snapshot

Cash runway
$11699M liquidity · $0M/mo burn
Low dilution risk
Lead asset
ibuzatrelvirPhase 1
Healthy →

Catalyst track record

+6%
best trade around PFE's most recent catalyst

Peak hindsight return over a 120-day window, across 15 tracked FDA/PDUFA catalysts for PFE.

See every catalyst's timing & PoA →